Gsa Capital Partners LLP Icad Inc Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.04 - $4.32 $152,414 - $322,760	74,713 Added 575.25%	87,701 $184,000
Q2 2022 Aug 09, 2022	BUY	$3.02 - $4.56 $39,223 - $59,225	12,988 New	12,988 $52,000
Q1 2022 May 11, 2022	SELL	$3.92 - $7.48 $141,123 - $269,287	-36,001 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.7 - $11.38 $241,206 - $409,691	36,001 New	36,001 $259,000
Q3 2021 Nov 12, 2021	SELL	$10.11 - $17.56 $214,554 - $372,658	-21,222 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$14.9 - $20.82 $316,207 - $441,842	21,222 New	21,222 $367,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.